Aleafia Health Inc. AH ALEAF raised $22.7 million via a previously announced bought deal offering.
Under the offering, vertically-integrated Canadian cannabis company issued 27.39 million units of the company, with a price tag of 83 cents for gross proceeds of $22.7 million, counting a partial exercise of the over-allotment option.
Cantor Fitzgerald Canada Corp. was named the lead underwriter and the only book-runner for the offering. The remaining underwriters included Echelon Wealth Partners Inc. and Mackie Research Capital Corp.
Under the offering, each unit is comprised of one company’s share and one-half of one share purchase warrant. Each warrant enables the owner to buy one share at a price of $1.05 in the next two years upon closing the offering.
Warrants issued under the offering should start trading on the Toronto Stock Exchange under the ticker symbol “AH.WT.B.”
Aleafia plans to utilize the collected net proceeds to support various development and working capital projects.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!